Tewtrakul Supinya, Tansakul Pimpimon, Panichayupakaranant Pharkphoom
Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand.
Phytomedicine. 2009 Oct;16(10):929-34. doi: 10.1016/j.phymed.2009.03.010. Epub 2009 Apr 28.
Three naphthoquinone derivatives, rhinacanthin-C (1), -D (2) and -N (3) were isolated from the extract of Rhinacanthus nasutus Kurz leaves and were tested for anti-allergic effect. The result indicated that all three compounds possessed very potent anti-allergic activity against antigen-induced beta-hexosaminidase release as a marker of degranulation in RBL-2H3 cells with IC(50) values of 6.9, 8.9 and 6.4 microM, respectively. In addition, the effects of rhinacanthin-C, -D and -N on antigen-induced release of TNF-alpha and IL-4 were also examined. It was found that rhinacanthin-C showed the most potent on antigen-induced TNF-alpha release with an IC(50) value of 0.7 microM, followed by rhinacanthin-D (IC(50)=3.8 microM) and rhinacanthin-N (IC(50)=10.3 microM), whereas those for IL-4 were rhinacanthin-D (IC(50)=5.4 microM), rhinacanthin-C (IC(50)=7.0 microM) and rhinacanthin-N (IC(50)=12.0 microM), respectively. The mechanisms in the late phase reaction of rhinacanthin-C, -D and -N were found to inhibit TNF-alpha and IL-4 gene expression in antigen-induced TNF-alpha and IL-4 releases on from RBL-2H3 cells as dose-dependent manners. The structure-activity trends of rhinacanthin-C,-D and-N on the inhibition of TNF-alpha release are as follow; substitution with octadienoic acid (rhinacanthin-C) conferred much higher activity than that of benzodioxo carboxylic acid ester (rhinacanthin-D) as well as naphthalene carboxylic acid ester (rhinacanthin-N). For the inhibition of IL-4 release, the substitution with octadienoic acid (rhinacanthin-C) and benzodioxo carboxylic acid ester (rhinacanthin-D) possessed the effect two-fold higher than that of naphthalene carboxylic acid ester (rhinacanthin-N). As regards active constituents for anti-allergic activity of R. nasutus, rhinacanthin-C, -D and -N are responsible for anti-allergic effect of this plant on both the early phase and late phase reactions. The finding may support the traditional use of R. nasutus leaves for treatment of allergy and allergy-related diseases.
从长穗爵床叶提取物中分离出三种萘醌衍生物,即长穗爵床素-C(1)、-D(2)和-N(3),并对其抗过敏作用进行了测试。结果表明,这三种化合物对RBL-2H3细胞中抗原诱导的β-己糖胺酶释放均具有很强的抗过敏活性,β-己糖胺酶释放是脱颗粒的标志物,其半数抑制浓度(IC50)值分别为6.9、8.9和6.4微摩尔。此外,还研究了长穗爵床素-C、-D和-N对抗原诱导的肿瘤坏死因子-α(TNF-α)和白细胞介素-4(IL-4)释放的影响。发现长穗爵床素-C对抗原诱导的TNF-α释放活性最强,IC50值为0.7微摩尔,其次是长穗爵床素-D(IC50=3.8微摩尔)和长穗爵床素-N(IC50=10.3微摩尔),而对IL-4释放的抑制作用则分别为长穗爵床素-D(IC50=5.4微摩尔)、长穗爵床素-C(IC50=7.0微摩尔)和长穗爵床素-N(IC50=12.0微摩尔)。长穗爵床素-C、-D和-N在晚期反应中的作用机制是在RBL-2H3细胞抗原诱导的TNF-α和IL-4释放中,以剂量依赖方式抑制TNF-α和IL-4基因表达。长穗爵床素-C、-D和-N对TNF-α释放抑制作用的构效关系如下:用十八碳二烯酸取代(长穗爵床素-C)比用苯并二恶唑羧酸酯(长穗爵床素-D)以及萘羧酸酯(长穗爵床素-N)具有更高的活性。对于IL-4释放的抑制作用,用十八碳二烯酸(长穗爵床素-C)和苯并二恶唑羧酸酯(长穗爵床素-D)取代的效果比萘羧酸酯(长穗爵床素-N)高两倍。至于长穗爵床抗过敏活性的活性成分,长穗爵床素-C、-D和-N对该植物在早期和晚期反应中的抗过敏作用均有贡献。这一发现可能支持长穗爵床叶治疗过敏及过敏相关疾病的传统用途。